206 related articles for article (PubMed ID: 10534470)
1. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.
Tangirala RK; Tsukamoto K; Chun SH; Usher D; Puré E; Rader DJ
Circulation; 1999 Oct; 100(17):1816-22. PubMed ID: 10534470
[TBL] [Abstract][Full Text] [Related]
2. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.
Kawashiri MA; Zhang Y; Puré E; Rader DJ
Atherosclerosis; 2002 Nov; 165(1):15-22. PubMed ID: 12208466
[TBL] [Abstract][Full Text] [Related]
5. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
Tsukamoto K; Tangirala R; Chun SH; Puré E; Rader DJ
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2162-70. PubMed ID: 10479659
[TBL] [Abstract][Full Text] [Related]
6. Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models.
Benoit P; Emmanuel F; Caillaud JM; Bassinet L; Castro G; Gallix P; Fruchart JC; Branellec D; Denèfle P; Duverger N
Circulation; 1999 Jan 5-12; 99(1):105-10. PubMed ID: 9884386
[TBL] [Abstract][Full Text] [Related]
7. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
9. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.
Van Craeyveld E; Gordts SC; Nefyodova E; Jacobs F; De Geest B
J Mol Med (Berl); 2011 Jun; 89(6):555-67. PubMed ID: 21249329
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
11. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
Li H; Reddick RL; Maeda N
Arterioscler Thromb; 1993 Dec; 13(12):1814-21. PubMed ID: 8241102
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo.
Zhang Y; Zanotti I; Reilly MP; Glick JM; Rothblat GH; Rader DJ
Circulation; 2003 Aug; 108(6):661-3. PubMed ID: 12900335
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent.
Lebherz C; Sanmiguel J; Wilson JM; Rader DJ
Cardiovasc Diabetol; 2007 May; 6():15. PubMed ID: 17475009
[TBL] [Abstract][Full Text] [Related]
15. Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1.
Kitajima K; Marchadier DH; Burstein H; Rader DJ
Atherosclerosis; 2006 May; 186(1):65-73. PubMed ID: 16099465
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis.
Wang L; Tian F; Arias A; Yang M; Sharifi BG; Shah PK
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):320-8. PubMed ID: 26499098
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
Pedersen TX; Bro S; Andersen MH; Etzerodt M; Jauhiainen M; Moestrup S; Nielsen LB
Atherosclerosis; 2009 Feb; 202(2):372-81. PubMed ID: 18489910
[TBL] [Abstract][Full Text] [Related]
18. Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE.
Harris JD; Graham IR; Schepelmann S; Stannard AK; Roberts ML; Hodges BL; Hill V; Amalfitano A; Hassall DG; Owen JS; Dickson G
Hum Mol Genet; 2002 Jan; 11(1):43-58. PubMed ID: 11772998
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice.
Jalkanen J; Leppänen P; Närvänen O; Greaves DR; Ylä-Herttuala S
Atherosclerosis; 2003 Jul; 169(1):95-103. PubMed ID: 12860255
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor.
Moore RE; Kawashiri MA; Kitajima K; Secreto A; Millar JS; Pratico D; Rader DJ
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1914-20. PubMed ID: 12933536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
